QA: Immuneering Corp in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001790340_2022_Immuneering_Corp.pdf

Logs

Graph

Absolute values for 0001790340, Immuneering Corp

  xvar xval
0 AssetsCurrent 152,333,996
1 IntangibleAssetsNetIncludingGoodwill 7,140,726
2 PropertyPlantAndEquipmentNet 807,223
3 remainder_Assets 6,422,887
4 LiabilitiesCurrent 5,633,826
5 LiabilitiesNoncurrent 5,090,897
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 1,153,073
8 SellingGeneralAndAdministrativeExpense 8,271,998
9 ResearchAndDevelopmentExpense 26,540,959
10 remainder_Expenses -307,485
11 remainder_Revenues 2,079,961
12 remainder_NetIncome 42,836
13 remainder_ComprehensiveNetIncome -49,009
  yvar yval
0 Assets 166,704,832
1 Liabilities 10,724,723
2 Expenses 35,658,545
3 Revenues 2,079,961
4 StockholdersEquity 155,980,109
5 NetIncome -33,535,748
6 ComprehensiveNetIncome -33,560,252
7 BaseVar 107,629,953
8 EconomicCapitalRatiobeforeLimitedLiability 3.45
9 EconomicCapitalRatio 4.00

Edgar->Model Mapping

Feature Distribution